JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$5.47B |
| 2 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.17B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$2.05B |
| 4 |
Amazon
AMZN
|
+$1.96B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.6B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$1.72B |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$1.31B |
| 3 |
UnitedHealth
UNH
|
+$1.26B |
| 4 |
Automatic Data Processing
ADP
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.08B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 27.28% |
| 2 | Technology | 17.17% |
| 3 | Healthcare | 10.79% |
| 4 | Financials | 9.36% |
| 5 | Consumer Discretionary | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5701
First Trust Europe AlphaDEX Fund
FEP
$503M
| $21.1K | ﹤0.01% |
606
+163
| +37% | +$5.67K |
2022 Q4
1 quarter
|
|
5702
Invesco DB Energy Fund
DBE
$115M
| $21K | ﹤0.01% |
1,000
| – | – |
2022 Q1
4 quarters
|
|
5703
State Street SPDR S&P International Dividend ETF
DWX
$506M
| $21K | ﹤0.01% |
620
| – | – |
2017 Q1
24 quarters
|
|
5704
Global Indemnity Group
GBLI
$359M
| $21K | ﹤0.01% |
746
+513
| +220% | +$14.5K |
2013 Q2
39 quarters
|
|
5705
Investar Holding Corp
ISTR
$404M
| $21K | ﹤0.01% |
1,524
+495
| +48% | +$9.54K |
2017 Q4
21 quarters
|
|
5706
Matinas BioPharma
MTNB
$2.76M
| $21K | ﹤0.01% |
60
| – | – |
2017 Q2
23 quarters
|
|
5707
Owlet
OWLT
$148M
| $21K | ﹤0.01% |
4,543
+3,877
| +582% | +$23K |
2021 Q3
6 quarters
|
|
5708
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$130M
| $21K | ﹤0.01% |
850
-23,151
| -96% | -$571K |
2022 Q3
2 quarters
|
|
|
SBI
5709
Western Asset Intermediate Muni Fund
SBI
$97.6M
| $21K | ﹤0.01% |
+2,597
| New | +$20.4K |
2023 Q1
0 quarters
|
|
5710
ProShares Short 20+ Year Treasury ETF
TBF
$141M
| $21K | ﹤0.01% |
988
-1,681
| -63% | -$36.3K |
2021 Q1
8 quarters
|
|
|
ABFL
5711
Abacus FCF Leaders ETF
ABFL
$541M
| $21K | ﹤0.01% |
+431
| New | +$20.6K |
2023 Q1
0 quarters
|
|
|
ALIM
5712
DELISTED
Alimera Sciences
ALIM
| $21K | ﹤0.01% |
10,364
+9,838
| +1,870% | +$22.9K |
2022 Q4
1 quarter
|
|
|
TYG
5713
Tortoise Energy Infrastructure Corp
TYG
$982M
| $20.4K | ﹤0.01% |
695
+621
| +839% | +$19.5K |
2022 Q4
1 quarter
|
|
5714
CALL
AB InBev
BUD
$147B
| $20K | ﹤0.01% |
+300
| New | +$18.1K |
2023 Q1
0 quarters
|
|
|
LGO
5715
Largo
LGO
$54.9M
| $20K | ﹤0.01% |
1,309
| – | – |
2021 Q2
7 quarters
|
|
|
NOVA
5716
CALL
DELISTED
Sunnova Energy
NOVA
| $20K | ﹤0.01% |
1,300
-3,700
| -74% | -$64.6K |
2022 Q2
3 quarters
|
|
5717
P3 Health Partners
PIII
$24.1M
| $20K | ﹤0.01% |
372
+97
| +35% | +$5.83K |
2022 Q1
4 quarters
|
|
|
PNNT
5718
Pennant Park Investment Corp
PNNT
$211M
| $20K | ﹤0.01% |
3,822
+61
| +2% | +$346 |
2013 Q2
39 quarters
|
|
5719
Pyxis Oncology
PYXS
$187M
| $20K | ﹤0.01% |
+5,033
| New | +$10.1K |
2023 Q1
0 quarters
|
|
|
SWZ
5720
Swiss Helvetia Fund
SWZ
$74.7M
| $20K | ﹤0.01% |
2,581
| – | – |
2015 Q4
29 quarters
|
|
5721
VistaGen Therapeutics
VTGN
$11.7M
| $20K | ﹤0.01% |
5,300
+1,610
| +44% | +$8.44K |
2021 Q2
7 quarters
|
|
|
SUNL
5722
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $20K | ﹤0.01% |
3,152
+2,464
| +358% | +$54.3K |
2021 Q3
6 quarters
|
|
5723
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11B
| $19.5K | ﹤0.01% |
732
+4
| +0.5% | +$111 |
2022 Q4
1 quarter
|
|
|
LKFT
5724
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.93B
| $19K | ﹤0.01% |
499
+35
| +8% | +$1.44K |
2019 Q1
16 quarters
|
|
|
GP
5725
GreenPower Motor Co
GP
$5.55M
| $19K | ﹤0.01% |
+615
| New | +$16.9K |
2023 Q1
0 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2023 Portfolio in Review
As of Q1 2023, JP Morgan Chase held 7,579 positions worth $821B, up 8.2% from $759B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2023 filing shows 751 new, 3,314 increased, 2,056 reduced and 652 closed positions. Its largest new stake was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M. The largest sale was Eli Lilly, an estimated $1.72B.
By sector, the portfolio is most concentrated in Miscellaneous at 27% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2023 buy was Near Intelligence, Inc. Common Stock: 5,852,099 shares worth $14.7M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q1 2023, an estimated $5.47B increase.
- JP Morgan Chase's biggest Q1 2023 reduction was Eli Lilly, cutting an estimated $1.72B.
- JP Morgan Chase fully exited IAA, Inc. Common Stock in Q1 2023, selling an estimated $155M.
- JP Morgan Chase's ten largest holdings make up 17% of its $821B portfolio in Q1 2023.
- JP Morgan Chase opened 751 new positions and closed 652 in Q1 2023.
- JP Morgan Chase's portfolio value rose 8.2% quarter-over-quarter to $821B.
Based on JP Morgan Chase's 13F filing for Q1 2023, filed 11 May 2023.